Audeotherapy.com
Audeotherapy.com

Privacy Policy

Privacy and Cookie Policy

Effective Date: 12/25/2024

Your privacy matters to us. This Privacy Policy explains how Audeotherapy, Inc. (“Audeotherapy,” “we,” “our,” or “us”) collects, uses, and protects your information. It applies to our website, mobile apps, forums, blogs, forms, and other online or offline services (collectively referred to as “Services”). By using our platform, you consent to the practices outlined in this Privacy Policy.

Overview of Services

Audeotherapy provides comprehensive resources and products for individuals and businesses seeking tailored solutions. As a licensed operator in multiple states, we comply with relevant privacy regulations, including the California Consumer Privacy Act (CCPA) and HIPAA.

In this policy, “you” and “your” refer to any user of our Services.

1. Information We Collect

Personal Information

We collect personal information necessary to provide our Services, such as:

  • Identity Details: Name, email address, mailing address, and phone number.
  • Payment Data: Billing address and credit card information for purchases.
  • Health Information: When required for certain services or products, relevant health-related details.

Optional Data

We may collect other information you choose to share, including:

  • Demographic data (e.g., age, gender, race).
  • Information is provided via job applications, surveys, or customer inquiries.

Required Data

Certain services or features require specific information, including:

  • Registering an account.
  • Entering promotions or contests.
  • Completing a purchase.
  • Communicating with our support team.

2. How We Use Your Information

We use the information we collect to:

  • Provide and improve our Services.
  • Notify you about products, services, or promotions that may interest you.
  • Customize content and recommendations based on your preferences.

3. Sharing Your Information

Audeotherapy does not sell, rent, or lease your information to third parties. However, we may share your data with trusted partners who assist in delivering our Services, including:

  • Statistical analysis.
  • Customer communications.
  • Delivery coordination.

These third-party partners are required to maintain the confidentiality of your information and may only use it for the agreed purposes.

Additionally, we may disclose your information:

  • To comply with legal obligations.
  • To protect the safety, rights, or property of Audeotherapy or its users.

4. Opt-Out of Data Sharing

Under applicable laws, including the CCPA and HIPAA, you have the right to opt out of having your personal information shared with third parties. To make a request or inquire about disclosure categories, visit our contact page at https://audeotherapy.com/contact-us.

5. Tracking and Cookies

Audeotherapy may monitor user activity across our Services to better understand engagement and preferences. This includes tracking data such as:

  • Website interactions.
  • Product and service preferences.

6. Automatically Collected Information

We may collect non-personal data such as:

  • IP address, browser type, and access times.
  • Referring website addresses.

This information helps us analyze trends and improve our Services.

7. External Links

Our platform may contain links to third-party websites. Audeotherapy is not responsible for the content or privacy practices of these websites. Users are encouraged to review their respective privacy policies.

8. Security of Your Information

We use encryption and other safeguards, such as Secure Sockets Layer (SSL), to protect your data during transmission. Despite these measures, no internet-based system can guarantee 100% security. By using our Services, you acknowledge the inherent risks associated with data transmission online.

9. Your Right to Deletion

You may request that we delete your personal information, subject to certain exceptions, such as:

  • Retaining data to complete transactions.
  • Complying with legal requirements.

To request deletion, contact us via the methods listed in the “Contact Information” section.

10. Children’s Privacy

Audeotherapy does not knowingly collect data from children under 13. If you are under 13, please seek permission from a parent or guardian before using our Services.

11. Opt-Out and Unsubscribe

To opt out of third-party communications or unsubscribe from emails, use the following methods:

  • Web Page: https://audeotherapy.com/contact-us
  • Email: [Insert Email Address]

Follow the unsubscribe instructions in any email to stop receiving further communications.

12. Data Storage

Your information may be stored on secure servers maintained by third-party hosting providers under contractual agreements with Audeotherapy.

13. Policy Updates

We may update this Privacy Policy periodically. Notifications about significant changes will be posted on our website or sent via email. Continued use of our Services after such updates indicates your acceptance of the revised policy.

14. Contact Information

For questions or concerns regarding this Privacy Policy, please contact us at:

Audeotherapy Inc.
[Address]
Email: [Insert Email Address]
Phone: [Insert Phone Number]

Effective Date: December 25, 2024.

Scroll to Top

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At AudeoTherapy, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.